DURBAN, South Africa — While the world has made progress reducing the number of people who die from AIDS every year by expanding access to life-saving drug treatments, many countries are increasingly failing to prevent the spread of HIV. That’s the disturbing gist of a new report released here at the 21st International AIDS Conference
While the guidelines are clear about the need to treat tuberculosis in the setting HIV infection, the reality is that many patients with HIV/TB co-infection Read More
No abstract available
Background: Limited data are available about the accuracy of postexposure prophylaxis (PEP) prescription in the emergency rooms.
Categories: CROI 2017SEATTLE – They are curious, impulsive and renownedly reckless. Studies have indicated they remain blissfully unaware of their risks, and unequipped to face them. Now, their numbers are growing fastest in countries that are home to great risks — where rates of HIV infection are among the world’s highest and where current approaches to testing and treatment already […](Read more…)
No abstract available
The Citizen: Tanzania: U.S. Warns Govt Ban May Stall HIV Fight “The United States [Saturday] warned the government against its decision to ban HIV/AIDS services at 40 health facilities, and introduce new guidelines for Key Populations (KP), saying the move could cause a flare-up of the epidemic among those afflicted. In a statement, the U.S.…More
Categories: CROI 2017SEATTLE – Providing immune cell testing and HIV treatment counseling immediately after a positive HIV test was the first in a series of measures that increased rapid linkage to care and retention at ten clinic sites in Mozambique, data presented here Thursday showed. Measures in a randomized trial of interventions in Maputo and Inhambane Province also […](Read more…)
Categories: CROI 2017Findings from first three of 13 countries in the Population-based HIV Impact Assessment show significant progress, highlight need for focused outreach SEATTLE – Zambia, Zimbabwe and Malawi, neighboring countries all hit hard by HIV across their populations, have all made similar strides that go beyond dropping numbers of new infections to rising numbers of people getting the […](Read more…)
Nature: Ebola funding surge hides falling investment in other neglected diseases “Global funding for research on neglected diseases — which include tuberculosis, HIV/AIDS, and malaria — is at its lowest level since 2007, according to the annual G-FINDER investment report by Policy Cures Research, a health policy analysis firm in Sydney, Australia. But that total…More
Abstract: The HIV epidemiology literature is replete with studies that categorize continuous predictors, such as age and CD4+ cell count.
Categories: CROI 2017SEATTLE – At CROI 2015 the results of the TEMPRANO trial showed that early initiation of antiretroviral therapy and six months of isoniazid preventive therapy significantly reduced illness including tuberculosis in patients with HIV. On Wednesday, Anani Badje from the TEMPRANO group provided long-term follow-up results from this same study that confirmed the value of […](Read more…)
Devex: Q&A: The director of the Gates Foundation’s HIV program on what’s needed to accelerate efforts “…Devex caught up with Emilio Emini, director of the HIV program at the [Bill & Melinda Gates Foundation], to check in on the progress that has been made in the prevention, diagnosis, and treatment of the disease, as well…More
Objective: The study aims to determine whether cystatin C is associated with HIV disease and HIV-associated neurocognitive impairment (NCI).